Wednesday, February 4, 2026
shahid-sha
Managing Editor @ShahidNShah

HEALTHCARE IT

CLINICAL RESEARCH

SEQUOIA Trial 6-Year Data on Zanubrutinib in del(17p) CLL Patients

Background Deletion 17p, written del(17p), is a high risk cytogenetic change in chronic lymphocytic leukemia, or CLL. Patients with del(17p) tend to do poorly with...

Buying Research Peptides: 10 Mistakes to Avoid

If you’re doing any kind of modern scientific research, then peptides are certainly going to be a part of it. Whether you’re trying to...

EHR

MEDICAL DEVICE

FEATURED ARTICLE

POPULAR POSTS

PATIENT ENGAGEMENT & PORTALS

FROM THE BLOG